These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

961 related items for PubMed ID: 23125220

  • 1. MicroRNA-144 promotes cell proliferation, migration and invasion in nasopharyngeal carcinoma through repression of PTEN.
    Zhang LY, Ho-Fun Lee V, Wong AM, Kwong DL, Zhu YH, Dong SS, Kong KL, Chen J, Tsao SW, Guan XY, Fu L.
    Carcinogenesis; 2013 Feb; 34(2):454-63. PubMed ID: 23125220
    [Abstract] [Full Text] [Related]

  • 2. MicroRNA-152 Targets Phosphatase and Tensin Homolog to Inhibit Apoptosis and Promote Cell Migration of Nasopharyngeal Carcinoma Cells.
    Huang S, Li X, Zhu H.
    Med Sci Monit; 2016 Nov 13; 22():4330-4337. PubMed ID: 27840403
    [Abstract] [Full Text] [Related]

  • 3. miR-18a promotes malignant progression by impairing microRNA biogenesis in nasopharyngeal carcinoma.
    Luo Z, Dai Y, Zhang L, Jiang C, Li Z, Yang J, McCarthy JB, She X, Zhang W, Ma J, Xiong W, Wu M, Lu J, Li X, Li X, Xiang J, Li G.
    Carcinogenesis; 2013 Feb 13; 34(2):415-25. PubMed ID: 23097559
    [Abstract] [Full Text] [Related]

  • 4. MicroRNA-106b promotes pituitary tumor cell proliferation and invasion through PI3K/AKT signaling pathway by targeting PTEN.
    Zhou K, Zhang T, Fan Y, Serick, Du G, Wu P, Geng D.
    Tumour Biol; 2016 Oct 13; 37(10):13469-13477. PubMed ID: 27465551
    [Abstract] [Full Text] [Related]

  • 5. miR-214 promotes tumorigenesis by targeting lactotransferrin in nasopharyngeal carcinoma.
    Deng M, Ye Q, Qin Z, Zheng Y, He W, Tang H, Zhou Y, Xiong W, Zhou M, Li X, Yan Q, Ma J, Li G.
    Tumour Biol; 2013 Jun 13; 34(3):1793-800. PubMed ID: 23479198
    [Abstract] [Full Text] [Related]

  • 6. miR-144-3p facilitates nasopharyngeal carcinoma via crosstalk with PTEN.
    Song L, Chen L, Luan Q, Kong Q.
    J Cell Physiol; 2019 Aug 13; 234(10):17912-17924. PubMed ID: 30834525
    [Abstract] [Full Text] [Related]

  • 7. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
    Lu C, Shan Z, Hong J, Yang L.
    Int J Oncol; 2017 Jul 13; 51(1):235-244. PubMed ID: 28534966
    [Abstract] [Full Text] [Related]

  • 8. MiR-155 promotes proliferation and inhibits apoptosis of nasopharyngeal carcinoma cells through targeting PTEN-PI3K/AKT pathway.
    Zuo WN, Zhu H, Li LP, Jin AY, Wang HQ.
    Eur Rev Med Pharmacol Sci; 2019 Sep 13; 23(18):7935-7942. PubMed ID: 31599418
    [Abstract] [Full Text] [Related]

  • 9. MicroRNA-146b promotes PI3K/AKT pathway hyperactivation and thyroid cancer progression by targeting PTEN.
    Ramírez-Moya J, Wert-Lamas L, Santisteban P.
    Oncogene; 2018 Jun 13; 37(25):3369-3383. PubMed ID: 29353884
    [Abstract] [Full Text] [Related]

  • 10. Upregulated TRIM29 promotes proliferation and metastasis of nasopharyngeal carcinoma via PTEN/AKT/mTOR signal pathway.
    Zhou XM, Sun R, Luo DH, Sun J, Zhang MY, Wang MH, Yang Y, Wang HY, Mai SJ.
    Oncotarget; 2016 Mar 22; 7(12):13634-50. PubMed ID: 26872369
    [Abstract] [Full Text] [Related]

  • 11. miR-10b promotes migration and invasion in nasopharyngeal carcinoma cells.
    Sun XJ, Liu H, Zhang P, Zhang XD, Jiang ZW, Jiang CC.
    Asian Pac J Cancer Prev; 2013 Mar 22; 14(9):5533-7. PubMed ID: 24175854
    [Abstract] [Full Text] [Related]

  • 12. MiR-205 promotes proliferation, migration and invasion of nasopharyngeal carcinoma cells by activation of AKT signalling.
    Mao Y, Wu S, Zhao R, Deng Q.
    J Int Med Res; 2016 Apr 22; 44(2):231-40. PubMed ID: 26880795
    [Abstract] [Full Text] [Related]

  • 13. EB-virus latent membrane protein 1 potentiates the stemness of nasopharyngeal carcinoma via preferential activation of PI3K/AKT pathway by a positive feedback loop.
    Yang CF, Yang GD, Huang TJ, Li R, Chu QQ, Xu L, Wang MS, Cai MD, Zhong L, Wei HJ, Huang HB, Huang JL, Qian CN, Huang BJ.
    Oncogene; 2016 Jun 30; 35(26):3419-31. PubMed ID: 26568302
    [Abstract] [Full Text] [Related]

  • 14. MiR-21 regulates biological behavior through the PTEN/PI-3 K/Akt signaling pathway in human colorectal cancer cells.
    Xiong B, Cheng Y, Ma L, Zhang C.
    Int J Oncol; 2013 Jan 30; 42(1):219-28. PubMed ID: 23174819
    [Abstract] [Full Text] [Related]

  • 15. MicroRNA-378 functions as an onco-miR in nasopharyngeal carcinoma by repressing TOB2 expression.
    Yu BL, Peng XH, Zhao FP, Liu X, Lu J, Wang L, Li G, Chen HH, Li XP.
    Int J Oncol; 2014 Apr 30; 44(4):1215-22. PubMed ID: 24481647
    [Abstract] [Full Text] [Related]

  • 16. MicroRNA-21 (Mir-21) Promotes Cell Growth and Invasion by Repressing Tumor Suppressor PTEN in Colorectal Cancer.
    Wu Y, Song Y, Xiong Y, Wang X, Xu K, Han B, Bai Y, Li L, Zhang Y, Zhou L.
    Cell Physiol Biochem; 2017 Apr 30; 43(3):945-958. PubMed ID: 28957811
    [Abstract] [Full Text] [Related]

  • 17. miR-205-5p regulates epithelial-mesenchymal transition by targeting PTEN via PI3K/AKT signaling pathway in cisplatin-resistant nasopharyngeal carcinoma cells.
    Zhang P, Lu X, Shi Z, Li X, Zhang Y, Zhao S, Liu H.
    Gene; 2019 Aug 20; 710():103-113. PubMed ID: 31158447
    [Abstract] [Full Text] [Related]

  • 18. MicroRNA-199a-3p suppresses the invasion and metastasis of nasopharyngeal carcinoma through SCD1/PTEN/AKT signaling pathway.
    Hu W, Wang Y, Zhang Q, Luo Q, Huang N, Chen R, Tang X, Li X, Luo H.
    Cell Signal; 2023 Oct 20; 110():110833. PubMed ID: 37543098
    [Abstract] [Full Text] [Related]

  • 19. DOC-2/DAB2 interactive protein regulates proliferation and mobility of nasopharyngeal carcinoma cells by targeting PI3K/Akt pathway.
    Wang B, Gu Q, Li J.
    Oncol Rep; 2017 Jul 20; 38(1):317-324. PubMed ID: 28586035
    [Abstract] [Full Text] [Related]

  • 20. miR-16 targets fibroblast growth factor 2 to inhibit NPC cell proliferation and invasion via PI3K/AKT and MAPK signaling pathways.
    He Q, Ren X, Chen J, Li Y, Tang X, Wen X, Yang X, Zhang J, Wang Y, Ma J, Liu N.
    Oncotarget; 2016 Jan 19; 7(3):3047-58. PubMed ID: 26655091
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 49.